Nevro Announces FDA Approval of Costa Rica Manufacturing Operations

REDWOOD CITY, Calif., Oct. 4, 2022 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced today that the U.S. Food and Drug Administration (FDA) has approved its…